Kezar Life Sciences, Inc. (KZR)
7.29
-0.07
(-0.95%)
USD |
NASDAQ |
May 08, 16:00
7.41
+0.12
(+1.65%)
After-Hours: 20:00
Kezar Life Sciences Total Liabilities (Quarterly) : 6.574M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Apellis Pharmaceuticals, Inc. | 705.11M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.65M |
| Shareholders Equity (Quarterly) | 70.07M |
| Debt to Equity Ratio | 0.0332 |
| Current Ratio | 11.52 |
| Net Debt Paydown Yield | 6.33% |